EP2491942
Use of cell-permeable peptide inhibitors of the JNK signal transduction pathway for the treatment of various cardiovascular diseases
Status:
EP einkaleyfi: Þýðing ekki lögð innEP appl. date:
2.6.2009EP published:
23.10.2013EP application number:
12000665.5
EPO information:
European Patent Register
Max expiry date:
1.6.2029
Title:
Use of cell-permeable peptide inhibitors of the JNK signal transduction pathway for the treatment of various cardiovascular diseases
Timeline
Today
2.6.2009EP application
23.10.2013EP Publication
Owner
Name:
Xigen Inflammation Ltd.Address:
Arch. Makariou III 195 Neocleous House, 3030, Limassol, CY
Inventor
Name:
Bonny, ChristopheAddress:
Lausanne, CH
Priority
Number:
PCT/EP2008/004341Date:
30.5.2008Country:
WO
Classification
Categories:
A61K 38/28, C07K 14/47, C07K 14/81, A61P 9/00